Ethacrynic acid,1 2,3-dichloro-4-(2 methylenebutyryl) -phenoxyacetic acid, is a recently introduced, orally effective natriuretic agent that is structurally unrelated to thiazides (1) and has proven useful in clinical disorders associated with edema (2-5). The present studies were undertaken to determine the natriuretic potency of this agent, its effect on the excretion of electrolytes other than sodium, and whether 'a specific site of action within the renal tubule is demonstrable. Current knowledge of the anatomical areas within the nephron where sodium transport leads to urinary concentration and dilution has been employed frequently for the purpose of localizing the tubular sites where natriuretic agents exert their effect (6-12). In the present studies, ethacrynic acid was given intravenously to dogs during water diuresis and during the elaboration of concentrated urine. The unique combination of changes in urinary dilution and concentration associated with the natriuretic effect of this agent is consistent with the concept that a major part of the natriuresis is due to interference with the transport of sodium by the ascending limb of Henle's loop. In addition, two drugsensitive sites of urinary dilution are apparent, one affected by chlorothiazide and the other by ethacrynic acid. intravenous infusion of isotonic saline, at 0.30 ml per minute, which contained inulin and p-aminohippurate (PAH) in amounts to deliver 10 mg and 3 mg per minute, respectively. This infusion was begun at least 1 hour before experimental collections were started. Urine was collected into graduated cylinders through an indwelling Foley catheter, and suprapubic pressure was employed at the end of each collection period. Blood samples were collected at the mid-point of experimental periods by free flow from an indwelling venous catheter into heparinized tubes. Studies in individual animals were conducted at intervals of no less than 7 days.
Ethacrynic acid,1 2,3-dichloro-4-(2 methylenebutyryl) -phenoxyacetic acid, is a recently introduced, orally effective natriuretic agent that is structurally unrelated to thiazides (1) and has proven useful in clinical disorders associated with edema (2) (3) (4) (5) . The present studies were undertaken to determine the natriuretic potency of this agent, its effect on the excretion of electrolytes other than sodium, and whether 'a specific site of action within the renal tubule is demonstrable. Current knowledge of the anatomical areas within the nephron where sodium transport leads to urinary concentration and dilution has been employed frequently for the purpose of localizing the tubular sites where natriuretic agents exert their effect (6) (7) (8) (9) (10) (11) (12) . In the present studies, ethacrynic acid was given intravenously to dogs during water diuresis and during the elaboration of concentrated urine. The unique combination of changes in urinary dilution and concentration associated with the natriuretic effect of this agent is consistent with the concept that a major part of the natriuresis is due to interference with the transport of sodium by the ascending limb of Henle's loop. In addition, two drugsensitive sites of urinary dilution are apparent, one affected by chlorothiazide and the other by ethacrynic acid.
Methods
Studies were carried out in four unanesthetized female mongrel dogs trained to stand quietly with the support of loose slings. Each animal received a constant * Submitted for publication February 5, 1964 ; accepted April 1, 1964. :Aided in part by grant AM-5401-02 from the National Institutes of Health.
tFellow of the Boston Medical Foundation, Inc. 1 intravenous infusion of isotonic saline, at 0.30 ml per minute, which contained inulin and p-aminohippurate (PAH) in amounts to deliver 10 mg and 3 mg per minute, respectively. This infusion was begun at least 1 hour before experimental collections were started. Urine was collected into graduated cylinders through an indwelling Foley catheter, and suprapubic pressure was employed at the end of each collection period. Blood samples were collected at the mid-point of experimental periods by free flow from an indwelling venous catheter into heparinized tubes. Studies in individual animals were conducted at intervals of no less than 7 days.
In samples of urine and plasma, inulin was determined by the method of Walser, Davidson, and Orloff (13) ,
PAH by a modification of the method of Smith and his colleagues (14) , chloride by amperometric titration (15) , sodium and potassium by internal standard flame photometry, and osmolality by the freezing point depression, using the Fiske osmometer.
Maximal hydropenia. Animals were deprived of water for 48 hours, and of food for 24 hours, before the experimental procedure. Sixteen to 18 hours before experiments, the animals received 5 U of vasopressin in oil 2 intramuscularly, and in all except one experiment ( hour, after the collection of control periods. In two experiments, the drug was administered, during an intermediate rate of infusion of hypertonic mannitol, and then the infusion of mannitol was discontinued. In one experiment, the drug was administered at the height of a hypertonic mannitol infusion (which was then discontinued), and in one experiment the agent was given when the flow of urine had receded after an infusion of hypertonic mannitol. In five of the six drug experiments described above, after the peak drug effect was observed, a hypertonic electrolyte solution (Na, 160; K, 4.0; Cl, 144; and HCO3, 20 mEq per L) was infused at a rate of 30 to 35 ml per minute, until a desired rate of urine flow was achieved. Despite the falling filtration rate, the natriuresis continued throughout the periods of observation (Table II) .
The effect of ethacrynic acid on urinary concentrating capacity (TCm20). In five experiments, TcHIo during the administration of ethacrynic acid was compared to that measured during the infusion of hypertonic mannitol. Three of these experiments were compared to control mannitol infusions performed on different days (dogs N, P, and R, Figure 1 ). In one experiment (dog B. Figure 1 ), ethacrynic acid was administered at the height of the hypertonic mannitol diuresis. In the remaining experiment (Table I) Figure 1 and Table I Figure 3 ). In one experiment (dog N, Table   III ), a second dose of ethacrynic acid produced only a small further decrease in CHSo, but an additional larger fall promptly followed the administration of chlorothiazide. In three experiments (Figure 3 ), chlorothiazide was administered at the height of water diuresis, and after two to four collection periods (during which time urinary losses were replaced in two of the studies by the infusion of hypotonic saline), ethacrynic acid was administered. The administration of chlorothiazide was associated with an initial decrease in CHO, as electrolyte excretion increased. The addition of ethacrynic acid produced a further decrease in CH2G (Table III, Figure 3 ). In one experiment (dog N, effects of each of these agents alone, on water diuresis and electrolyte excretion in the same animals (on different days), is shown in Table IV. Discussion Ethacrynic acid represents a new class of natriuretic compounds (1); in early clinical trials it has proven to be an orally effective diuretic agent (2) (3) (4) (5) . In our present studies, the agent proved to be natriuretic and chloruretic during intravenous administration in the dog, with a potency comparable to that reported for organomercurials (16) . Although no systematic attempt was made to determine the maximal effect of the drug, repeated intravenous injections of 1 mg per kg to dogs undergoing diuresis (kept in approximate electrolyte balance by the infusion of a hypotonic solution similar in composition to the excreted urine) did not result in rates of sodium excretion significantly greater than the peak observed after the initial dose. The dose of ethacrynic acid employed in these studies' is therefore assumed to have resulted in a near maximal effect of the agent on electrolyte excretion. At the rate of administration of chlorothiazide and ethacrynic acid that we employed, the two agents are clearly additive in increasing solute excretion. The constant administration of ethacrynic acid is associated with continuing electrolyte depletion that ap-1501 pears to result in compensatory mechanisms (such as the observed decreases in glomerular filtration rate) that preclude a stable diuretic effect. It is therefore difficult to evaluate the relative natriuretic potency of the two agents during sequential administration. In the present studies, the increased excretion of sodium associated with the administration of chlorothiazide alone was simi-'lar to that observed in dogs under the same conditions in other studies (12) . The natriuretic effect of ethacrynic acid alone was three to four times as great as that observed with chlorothiazide alone. Knowledge of the sites within the nephron where the reabsorption of filtered solute leads to urinary dilution and concentration (17, 18) has provided a useful tool for localizing the anatomical areas where natriuretic agents may impair the net reabsorption of sodium. Urinary dilution apparently begins in the ascending limb of Henle's loop, and, in the absence of antidiuretic hormone, probably continues through more distal areas of the nephron ( 17, 18) , although direct evidence for this more distal site of dilution is lacking. Therefore, an agent that impairs electrolyte reabsorption in the proximal portions of the nephron would result in a greater delivery of isotonic fluid to these distal diluting sites and thereby increase the generation of free water during water diuresis. Acetazoleamide has such an effect during water diuresis (6, 7, 12) , and, on the basis of such evidence alone, it has been suggested that the natriuretic effect of carbonic anhydrase inhibitors resides largely in the proximal nephron. This interpretation has been supported by the results of micropunctures which demonstrate that the major fraction of filtered bicarbonate is reabsorbed in the proximal convolution (19, 20) . Chlorothiazide, on the other hand, results in an increased excretion of solute and a decreased excretion of free water during maximal water diuresis in both man and the dog (11, 12) . On the basis of this evidence, it has been suggested that this latter agent interferes with sodium reabsorption in distal portions of the nephron where sodium transport results in the production of dilute tubular fluid (11, 12) . Thiazides do not decrease the renal concentrating capacity (TcH1o), as would be expected if a major decrease occurred in the transport of solute by the ascending limb of Henle's loop. Therefore, it has been suggested that thiazides interfere with net sodium reabsorption at diluting sites distal to Henle's loop (11, 12) . This conclusion has received some support from stop-flow analyses that are consistent with a distal site of action of chlorothiazide (21, 22) . The effect of organomercurials on the renal concentrating and diluting mechanisms appears more complex than that of carbonic anhydrase inhibitors or thiazides (8) (9) (10) . However, the natriuresis resulting from the administration of organomercurials may not be associated with major decreases in either TCHO or CH2O (8) (9) (10) .
In our studies, the administration of ethacrynic acid was accompanied by the virtual disappearance of the ability to excrete a concentrated urine. This observation alone is consistent with the view that this agent may markedly decrease the transport of electrolyte by the ascending limb of Henle's loop. However, other factors such as membrane permeability, glomerular filtration rate (23) , and the rate of solute excretion (12, 23) may influence the renal concentrating mechanism, as measured by TCHeO. In the present studies, TCH20 was measured, during the administration of ethacrynic acid, through a wide range of solute excretion and at various rates of glomerular filtration (which overlapped with the same measurements during the control studies with hypertonic mannitol infusion). TCHeo was completely abolished or markedly decreased, regardless of the rate of solute excretion, and concentrating ability was not restored when glomerular filtration rate was increased by the infusion of hypertonic saline.
If ethacrynic acid does decrease the transport of solute by Henle's loop, then its action should also be manifested by decreased diluting ability, since this tubular transport site results in both urinary concentration and dilution (17, 18) . Such an effect on CH.,O was observed in our studies. During the leak natriuresis, free water excretion was reduced from control values by an average of 53%o. In earlier studies, we had observed that after approximately 20 minutes of drug administration, CH2o began to progressively decrease, in association with a decrease in solute excretion. Since this delayed fall also was associated with a decreasing glomerular filtration rate, we considered the possibility that the progressive fall in CH20 might be the result of the electrolyte depletion induced by the drug. This conclusion appeared to be correct, since the replacement of druginduced electrolyte losses (by the infusion of a hypotonic electrolyte solution) resulted in relatively stable values for both CH1o and glomerular filtration rate.
Although ethacrynic acid uniformly reduced the excretion of free water, the effect of the agent on CH9O during the "steady state" (replacement of electrolyte losses) appeared less marked than the effect on TcHO. These observations are consistent with the view that ethacrynic acid may markedly decrease electrolyte transport by the loop of Henle and that a more distal site of urinary (lilultion may exist which is not impaired by the drug. It has been suggested that chlorothiazide (which decreases CH20 but not TCH20) may interfere with electrolyte reabsorption at diluting sites distal to Henle's loop (11, 12) . It water. It has been suggested that a significant fraction of the filtered sodium may be reabsorbed "isotonically" in the distal nephron, even during water diuresis (9) . An action of ethacrynic acid at such a site, in combination with an action in Henle's loop, could not be distinguished from a combined effect of the agent on the reabsorption of electrolyte by the proximal convolution and Henle's loop.
The relationship between the increased excretion of chloride induced by ethacrynic acid and the total of sodium and potassium excretion is consistent with the premise that this agent acts at tubular sites where reabsorption involves both sodium and chloride. The data provide no information as to how net electrolyte reabsorption is impaired by the drug. The differences that exist between the effects of ethacrynic acid and organomercurials (8) (9) (10) on TCH2o and CH2o make it likely that these two agents also have different mechanisms of action within the nephron. This suggestion is supported by reports that these drugs have additive diuretic effects (3, 5). The increased excretion of potassium associated with the natriuresis induced by ethacrynic acid may be due to increased cation exchanges in the distal nephron (24) , and, in itself, does not imply a special effect of the drug on the excretion of potassium. Summary Ethacrynic acid was administered intravenously to dogs during hydropenia with vasopressin infusion and during maximal water diuresis. The diuretic effect of the drug began within 2 minutes, and peak natriuresis occurred within 20 minutes. Potassium excretion increased, and chloride excretion approached the sum of cation excretion. The agent had a natriuretic potency three to four times that of chlorothiazide, with an average maximal effect resulting in the excretion of 17%o of the filtered sodium.
The renal concentrating ability was virtually abolished by ethacrynic acid. During water diuresis, the drug uniformly reduced, but did not eliminate, free water clearance. The addition of chlorothiazide always resulted in a further decrease in free water clearance. The two agents were additive in decreasing free water clearance and increasing solute excretion, regardless of the sequence of administration.
We suggest that an important part of the natriuresis produced by ethacrynic acid results from an interference with reabsorption of electrolyte by the ascending limb of Henle's loop. In addition, the drug may exert a significant effect on proximal electrolyte reabsorption. These data are consistent with the premise that two drug-sensitive sites of urinary dilution exist. 1) The loop of Henle, where electrolyte transport is common to both urinary dilution and concentration, is affected by ethacrynic acid and probably not by chlorothiazide. 2) A more distal site of urinary dilution, not directly involved in the concentrating mechanism, may be affected by chlorothiazide and probably not by ethacrynic acid.
